Xiaozhao Lu
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Extracellular vesicles in disease
Papers in
-
- RNA modifications and cancer 8
- RNA Research and Splicing 7
-
- Cardiovascular Function and Risk Factors 7
- Cardiac Fibrosis and Remodeling 3
- Co-authors
- Guodong Yang (13 shared papers)Lijun Yuan (2 shared papers)Zifan Lu (9 shared papers)Haiyan Fu (8 shared papers)Mengying Wei (8 shared papers)Jun Pu (3 shared papers)Ning Wu (2 shared papers)Huanyu Lu (4 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (4 papers)Reviews in Cardiovascular Medicine (2 papers)Cancer Biology & Therapy (2 papers)Cardiovascular Diabetology (2 papers)Gastroenterology (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Xiaozhao Lu
36 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Cancer Research 1.0k
- Molecular Biology 1.2k
- Cardiology and Cardiovascular Medicine 130
- Nephrology 36
- Endocrinology, Diabetes and Metabolism 66
Countries citing papers authored by Xiaozhao Lu
This map shows the geographic impact of Xiaozhao Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozhao Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozhao Lu more than expected).
Fields of papers citing papers by Xiaozhao Lu
This network shows the impact of papers produced by Xiaozhao Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozhao Lu. The network helps show where Xiaozhao Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaozhao Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | LncRNA: A link between RNA and cancer Hit paper breakdown → | 2014 | 825 |
| 2 | 2009 | 113 | |
| 3 | 2013 | 74 | |
| 4 | 2012 | 61 | |
| 5 | 2012 | 50 | |
| 6 | 2013 | 49 | |
| 7 | 2015 | 44 | |
| 8 | 2022 | 31 | |
| 9 | 2017 | 31 | |
| 10 | 2012 | 31 | |
| 11 | 2017 | 27 | |
| 12 | 2014 | 24 | |
| 13 | 2011 | 24 | |
| 14 | 2018 | 23 | |
| 15 | 2016 | 22 | |
| 16 | 2013 | 18 | |
| 17 | 2022 | 17 | |
| 18 | 2023 | 15 | |
| 19 | 2015 | 13 | |
| 20 | 2021 | 6 |
About Xiaozhao Lu
Xiaozhao Lu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Cancer Research, Nephrology and Oncology, having authored 36 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (8 papers), RNA Research and Splicing (7 papers), Cardiovascular Function and Risk Factors (7 papers), Chronic Kidney Disease and Diabetes (4 papers), Cancer-related molecular mechanisms research (4 papers), Cancer Cells and Metastasis (3 papers), Diabetes Treatment and Management (3 papers) and Cardiac Fibrosis and Remodeling (3 papers). The work is most often cited by research in Cancer Research (1.0k citations), Molecular Biology (1.2k citations), Cardiology and Cardiovascular Medicine (130 citations), Nephrology (36 citations) and Endocrinology, Diabetes and Metabolism (66 citations). Xiaozhao Lu has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Guodong Yang, Lijun Yuan, Zifan Lu, Haiyan Fu, Mengying Wei, Jun Pu, Ning Wu, Huanyu Lu, Liang Jin and Libo Yao. Their work appears in journals such as Biochemical and Biophysical Research Communications, Reviews in Cardiovascular Medicine, Cancer Biology & Therapy, Cardiovascular Diabetology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.